Butyrate, in particular, enhances the expression of CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) on Tregs, which suppresses immune responses and promotes an immunosuppressive environment that may affect tumor growth and immune tolerance [27]. This evidence concerns the gene CTLA4 and neoplasm.